Publications en collaboration avec des chercheurs de AstraZeneca (United Kingdom) (16)

2024

  1. Trastuzumab deruxtecan in breast cancer

    Critical Reviews in Oncology/Hematology, Vol. 198

2021

  1. Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs

    Nature Communications, Vol. 12, Núm. 1

  2. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 10, pp. 2612-2617

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59

2017

  1. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts

    Leukemia Research, Vol. 56, pp. 82-87

  2. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

    British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265

  3. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

    Journal of Hematology and Oncology, Vol. 10, Núm. 1

2016

  1. Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes

    PLoS ONE, Vol. 11, Núm. 10

2015

  1. A low frequency of losses in 11q chromosome is associated with better outcome and lower rate of genomic mutations in patients with chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 12

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients

    Addictive Behaviors, Vol. 36, Núm. 3, pp. 265-269

  2. Estimation of a multiattribute utility function for the Spanish version of the tool questionnaire

    Value in Health, Vol. 14, Núm. 4, pp. 564-570

2009

  1. Pharmacoeconomic analysis of switching antipsychotic treatment, for inefficiency or adverse effects, to extended-release quetiapine

    Pharmacoeconomics - Spanish Research Articles, Vol. 6, Núm. 4, pp. 105-114

2006

  1. Neurohormonal blockade in patients with heart failure at discharge from hospital

    Anales de Medicina Interna, Vol. 23, Núm. 10

2005

  1. A 6-month prospective observational study on the effects of quetiapine on sexual functioning

    Journal of Clinical Psychopharmacology, Vol. 25, Núm. 6, pp. 533-538